Marshall Wace
EQ icon

Marshall Wace’s Equillium EQ Stock Holding History

Marshall Wace’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,632
Closed -$115K – 3319
2026
Q1 		$115K Buy
+57,632
New +$94.8K ﹤0.01% 2879
2025
Q4 		– Sell
-41,220
Closed -$58.9K – 3098
2025
Q3 		$58.9K Buy
+41,220
New +$43.6K ﹤0.01% 2715
2024
Q2 		– Sell
-11,897
Closed -$27.5K – 2653
2024
Q1 		$27.5K Buy
+11,897
New +$20.7K ﹤0.01% 2366

Other funds holding EQ

JT
Jupiter Topco New York $245B AUM
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Marshall Wace's EQ Position: Q2 2026 in Review

Marshall Wace sold out of Equillium (EQ) in Q2 2026, closing a stake of 57,632 shares — an estimated $115K sold.

Marshall Wace first reported a position in EQ in Q1 2024 and held it in 3 quarters. The position peaked at $115K in Q1 2026. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

  • Marshall Wace reported no remaining Equillium position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 57,632 Equillium shares in Q2 2026, an estimated $115K.
  • Marshall Wace first reported a position in Equillium in Q1 2024 and held it in 3 quarters.
  • Marshall Wace's Equillium position peaked at $115K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.